A Tale of Two Transparency Attempts at FDA

被引：0
|
作者：
Tai, Laurence [1 ]
机构：
[1] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA
来源：
FOOD AND DRUG LAW JOURNAL | 2013年 / 68卷 / 04期
关键词：
INFORMATION; DISCLOSURE; BUSINESS; SECRETS; HEALTH;
D O I：
暂无
中图分类号：
TS2 [食品工业];
学科分类号：
0832 ;
摘要：
引用
收藏
页码：423 / 447
页数：25
相关论文
共 50 条
  • [1] The FDA: A dromedary tale
    不详
    NATURE BIOTECHNOLOGY, 1997, 15 (01) : 1 - 1
  • [2] The FDA: A dromedary tale
    Nature Biotechnology, 1997, 15 (1) : 1 - 1
  • [3] FDA's commitment to transparency
    Guharoy, Roy
    Krenzelok, Edward
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2021, 78 (17) : 1550 - 1551
  • [4] Increasing transparency at the FDA: The impact of the FDA Amendments Act of 2007
    Wood, Susan F.
    Perosino, Kristen L.
    PUBLIC HEALTH REPORTS, 2008, 123 (04) : 527 - 530
  • [5] FDA Seeks Transparency in Data and Decisions
    Wechsler, Jill
    BIOPHARM INTERNATIONAL, 2010, 23 (07) : 18 - 19
  • [6] FDA Transparency in an Inescapably Political World
    Carpenter, Daniel
    JOURNAL OF LAW MEDICINE & ETHICS, 2017, 45 : 29 - 32
  • [7] Commentary: Data monitoring confidentiality and FDA transparency
    London, Alex John
    CLINICAL TRIALS, 2015, 12 (01) : 12 - 14
  • [8] Regulatory Transparency: Forthcoming Lessons from the FDA
    Chakraborty, Sweta
    Lofstedt, Ragnar E.
    EUROPEAN JOURNAL OF RISK REGULATION, 2010, 1 (02) : 159 - 162
  • [9] The FDA, Juno Therapeutics, and the ethical imperative of transparency
    Hey, Spencer Phillips
    Kesselheim, Aaron S.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [10] Navigating Hospital Price Transparency—a Cautionary Tale
    Shivani A. Shah
    Zirui Song
    Journal of General Internal Medicine, 2022, 37 : 1306 - 1309
12345